OCGN — Ocugen Cashflow Statement
0.000.00%
- $210.02m
- $180.17m
- $4.06m
Annual cashflow statement for Ocugen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -21.8 | -58.4 | -81.4 | -63.1 | -54.1 |
Depreciation | |||||
Non-Cash Items | 8.22 | 7.76 | 11.6 | 13.5 | 6.28 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.21 | 2.44 | 9.2 | -13.2 | 3.67 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -14.7 | -47.9 | -60.1 | -62.1 | -42.1 |
Capital Expenditures | -0.307 | -1.07 | -4.46 | -10.5 | -3.38 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | -0.75 | -12.5 | 13.6 | 0 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.307 | -1.82 | -17 | 3.08 | -3.38 |
Financing Cash Flow Items | -1.48 | -8.53 | -0.592 | -0.423 | -3.7 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 31.6 | 121 | 59.5 | 20.9 | 64.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 16.6 | 70.9 | -17.5 | -38.1 | 19.4 |